Drug Shortage Report for HEPTOVIR
| Report ID |
18727 |
| Drug Identification Number |
02239194 |
| Brand name |
HEPTOVIR |
| Common or Proper name |
lamivudine oral solution |
| Company Name |
GLAXOSMITHKLINE INC |
| Market Status |
MARKETED |
| Active Ingredient(s) |
LAMIVUDINE |
| Strength(s) |
5MG |
| Dosage form(s) |
SOLUTION |
| Route of administration |
ORAL |
| Packaging size |
240 mL |
| ATC code |
J05AF |
| ATC description |
DIRECT ACTING ANTIVIRALS |
| Reason for shortage |
Demand increase for the drug. |
| Anticipated start date |
|
| Actual start date |
2017-08-02 |
| Estimated end date |
2017-09-22 |
| Actual end date |
2017-09-12 |
| Shortage status |
Resolved |
| Updated date |
2017-09-13 |
| Company comments |
|
| Health Canada comments |
|
| Company contact information |
1-800-387-7374 |
Version History
Click on "Compare" below to view the full report history and compare to other
versions.
